Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study

Summary

This multicenter, cross-sectional observational study aims to evaluate the impact of financial toxicity on caregiver burden, quality of life, and emotional distress among hospitalized adult cancer patients. Participants will complete validated Turkish versions of the Zarit Caregiver Burden Scale, the EORTC QLQ-C30, and the Hospital Anxiety and Depression Scale (HADS). Financial toxicity will be assessed through indicators such as household income, treatment-related costs, and insurance coverage. Informed consent will be obtained from all participants. The study will not impose any financial burden on the participants or the hospital. Data collection is planned between August 1, 2025 and January 15, 2026 at three tertiary centers: Etlik City Hospital, Gazi University Faculty of Medicine, and Kocaeli University Faculty of Medicine in Turkey. The findings are expected to contribute to the development of targeted support strategies for patients and caregivers in oncology settings.

Eligibility

Inclusion Criteria:

* Age ≥ 18 years
* Histologically confirmed solid organ malignancy
* Currently receiving inpatient care in the medical oncology service
* Receiving active oncologic treatment and/or supportive care
* Fluent in Turkish (reading and speaking)
* Capable of understanding and answering the administered surveys
* Signed informed consent form

Exclusion Criteria:

* ICU admission at the time of enrollment
* ECOG Performance Status ≥3 or cognitive/clinical condition preventing completion of questionnaires
* Severe cognitive impairment or psychiatric condition interfering with survey participation
* Failure to provide informed consent

Conditions5

Browse More Trials